awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41418443-3BC652A3-FE80-41B6-866E-4B16BE3BAFE3
Q41418443-3BC652A3-FE80-41B6-866E-4B16BE3BAFE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41418443-3BC652A3-FE80-41B6-866E-4B16BE3BAFE3
MET expression during prostate cancer progression.
P2860
Q41418443-3BC652A3-FE80-41B6-866E-4B16BE3BAFE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41418443-3BC652A3-FE80-41B6-866E-4B16BE3BAFE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c326d2aaa9c43efd18cebc23ee186f95f369b0ab
P2860
Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.